Virbac (Virbac) COGS-to-Revenue : 0.34 (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Virbac COGS-to-Revenue?

Virbac's Cost of Goods Sold for the six months ended in Jun. 2023 was $227 Mil. Its Revenue for the six months ended in Jun. 2023 was $661 Mil.

Virbac's COGS to Revenue for the six months ended in Jun. 2023 was 0.34.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Virbac's Gross Margin % for the six months ended in Jun. 2023 was 65.74%.

Virbac COGS-to-Revenue Historical Data

The historical data trend for Virbac's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac COGS-to-Revenue Chart

Virbac Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

Get a 7-Day Free Trial

0.34

0.35

Virbac Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
COGS-to-Revenue	Get a 7-Day Free Trial															0.33	0.35	0.35	0.35	0.34

Virbac COGS-to-Revenue Calculation

Virbac's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	451.506	/	1288.334
	=	0.35

Virbac's COGS to Revenue for the quarter that ended in Jun. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	226.588	/	661.395
	=	0.34

Virbac (OTCPK:VRBCF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Virbac's Gross Margin % for the six months ended in Jun. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	226.588 / 661.395
	=	65.74 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Virbac COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Virbac's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Virbac (Virbac) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (OTCPK:VRBCF) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

0NM7:UK VIRP:France V16:Germany

Address

2065m LID, 1 ere avenue, Carros, FRA, 06516

Website

https://www.virbac.com

Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America.